SCHEMBL3496129

SCHEMBL3496129

N#CC(O)c1cccc(O)c1

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ESR1 P03372 2/20 0.59
ESR2 Q92731 2/20 0.59
TSHR P16473 3/20 0.59
ADRB1 P08588 2/20 0.48
ADRA1A P35348 2/20 0.48
MIF P14174 1/20 0.48
HTR2A P28223 1/20 0.48
HTR2B P41595 1/20 0.48
HIF1A Q16665 4/20 0.46
ADRB2 P07550 1/20 0.46
HTR1A P08908 1/20 0.46
ADRA2A P08913 1/20 0.46
ADRB3 P13945 1/20 0.46
ADRA2B P18089 1/20 0.46
ADRA2C P18825 1/20 0.46
NFKB1 P19838 1/20 0.46
DRD1 P21728 1/20 0.46
HTR7 P34969 1/20 0.46
ADRA1B P35368 1/20 0.46
DRD3 P35462 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7262478 1.00 ESR1 (0.59) ESR1ESR2TSHRADRB1ADRA1A
SCHEMBL9256909 1.00 ESR1 (0.59) ESR1ESR2TSHRADRB1ADRA1A
SCHEMBL8944137 0.79 ADRB1 (0.48) ESR1ESR2TSHRADRB1ADRA1A
SCHEMBL6966592 0.79 ADRB1 (0.48) ESR1ESR2TSHRADRB1ADRA1A
SCHEMBL6691199 0.78 TSHR (0.57) ESR1ESR2TSHRADRB1ADRB2
SCHEMBL198178 0.78 TSHR (0.57) ESR1ESR2TSHRSLC6A3ALDH1A1
SCHEMBL2162950 0.78 TSHR (0.57) ESR1ESR2TSHRLMNAALDH1A1
SCHEMBL21807151 0.78 TSHR (0.57) ESR1ESR2TSHRHIF1ARAB9A
SCHEMBL7767485 0.78 ESR1 (0.58) ESR1ESR2TSHRADRB1ADRA1A
SCHEMBL9176673 0.78 TSHR (0.57) ESR1ESR2TSHRGAAALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100137636-A1 IDENTIFICATION OF A NITRILASE FROM B. JAPONICUM BY RATIONAL GENOME MINING AND METHODS OF USE SOUTHERN METHODIST UNIVERSITY 2010-06-03 US disclosed
US-7622585-B2 Phenylglycinamide derivatives useful as anticoagulants BRISTOL-MYERS SQUIBB COMPANY (US) 2009-11-24 US disclosed
US-7456195-B2 Phenylglycinamide and pyridylglycinamide derivatives useful as anticoagulants BRISTOL-MYERS SQUIBB COMPANY (US) 2008-11-25 US disclosed
US-20070178575-A1 Identification Of A Nitrilase From B. Japonicum By Rational Genome Mining And Methods Of Use SOUTHERN METHODIST UNIVERSITY 2007-08-02 US disclosed
US-5008192-A Enzymatic process for the preparation of optically active cyanohydrins KERNFORSCHUNGSANLAGE JUELICH GMBH (DE) 1991-04-16 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100137636-A1 IDENTIFICATION OF A NITRILASE FROM B. JAPONICUM BY RATIONAL GENOME MINING AND METHODS OF USE BLVRB, BBOX1, GGH ESR1 2303/4885ESR2 2628/4885TSHR 4014/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.